BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 19, 2001

View Archived Issues

Bayer and CuraGen establish two collaborative agreements

Read More

Bioniche's MCC technology approved for prostate cancer clinical trials

Read More

Study of RSR-13 in combination with chemotherapy commences

Read More

Amylin reports company update and projections

Read More

Aphton to commence study of GnRH pharmaccine in combination with Taxotere

Read More

First once-monthly injectable contraceptive now available in the U.S.

Read More

World's first diagnostic agent for Parkinson's disease reaches market in Europe

Read More

Aventis Pasteur launches Hexavac, a significant advance in childhood vaccination

Read More

Worldwide licensing arrangement announced for TZT-1027

Read More

YM-905 enters late-stage clinical development overseas

Read More

Novogen receives grant for development of antiinflammatory drug

Read More

Traditional Chinese medicine has beneficial effects on body fat and triglycerides in animal model

Read More

Ligand's Ontak enters phase II for CLL

Read More

Halofuginone affects critical steps in the angiogenic process

Read More

Patient enrollment in OCTAVE hypertension trial nears completion

Read More

Phase II trials of ADL-8-2698 in opioid-induced bowel dysfunction successfully completed

Read More

Allergan obtains rights to compound for PDT of age-related macular degeneration

Read More

Combinations of lipopeptides and other antifungal agents reported to be synergistic

Read More

Neurochem cleared to advance Fibrillex to phase II/III clinical trials in the U.K.

Read More

Novel combination therapies useful for weight gain associated with antipsychotic drugs

Read More

Use of rhIL-11 for the treatment of hemorrhagic shock described by Genetics Institute

Read More

New series of 5-HT7 antagonists designed by the former SB

Read More

Inhibitors of NOS and their therapeutic use claimed in recent patents by AstraZeneca

Read More

Clinical evaluation of FKK-138 following single bolus doses

Read More

Antitumor compounds active against solid tumors and leukemias in the ADIR pipeline

Read More

Japanese team discloses new aldose reductase inhibitors

Read More

Quinazoline ACAT inhibitors and their use in lipid disorders

Read More

Antifungal antibiotic isolated from Penicillium sp. at Takara Shuzo

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 9, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing